Waterjet Versus Ultrasound Dissection During Hepatic Transection

Sponsor
Karolinska University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT02041065
Collaborator
Bengt Isaksson (Other), Jansson, Anders, M.D. (Other)
84
1
2
48.9
1.7

Study Details

Study Description

Brief Summary

Before liver transection patients are allocated to either waterjet or CUSA to divide the liver parenchyma.

Condition or Disease Intervention/Treatment Phase
  • Device: Waterjet induced dissection
  • Device: CUSA induced dissection
Phase 2

Detailed Description

Transection time, bloodloss, total operation time and postoperative complication rates are registered.

Study Design

Study Type:
Interventional
Actual Enrollment :
84 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Waterjet Versus Ultrasound Dissection During Hepatic Transection
Study Start Date :
Feb 1, 2011
Actual Primary Completion Date :
Feb 1, 2015
Actual Study Completion Date :
Mar 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Experimental: Waterjet induced dissection

Waterjet induced dissection of the liver during resection.Waterjet dissection device mechanically separates hepatic tissue from bile ducts and vessels, the latter two to be separately ligated.

Device: Waterjet induced dissection
Waterjet induced dissection of the liver during resection.Waterjet dissection device mechanically separates hepatic tissue from bile ducts and vessels, the latter two to be separately ligated.

Active Comparator: CUSA induced dissection

CUSA transection of the liver. Ultrasound based destruction of the liver parenchyma to allow separate ligation of the bile duct and intrahepatic vessels.

Device: CUSA induced dissection
Ultrasound based destruction of the liver

Outcome Measures

Primary Outcome Measures

  1. Peroperative bloodloss [During liver transection (on an average<90 min)]

    Peroperative bloodloss in ml during liver transection by use of either waterjet or CUSA.

Secondary Outcome Measures

  1. Transection time in minutes [During liver transection (on an average< 90 minutes)]

  2. Operation time in minutes [Time spent in theater in minutes (on an average <240 minutes)]

  3. Hospital stay in days [Days spent in hospital after surgery (on an average < 10 days)]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Hepatic tumour suitable for resection

  • patients 18 year or older Segmental resection Local resection Left sided hemihepatectomy

Exclusion Criteria:
  • Right sided hemihepatectoyReresection In Situ Split Liver Extended left- and rightsided hemihepatectomy Lobus caudatus resection Central resections Hilus tumour/Klatskin/Cholangiocarcinoma Surgery on biliary tree Extended resection on other organs

Resection on gallbladder Resection on other organs during the same operation.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Karolinska University Hospital, Centra of Gastroenterology Stockholm Sweden 14186

Sponsors and Collaborators

  • Karolinska University Hospital
  • Bengt Isaksson
  • Jansson, Anders, M.D.

Investigators

  • Study Chair: Anders Jansson, MdPhd, Karolinska University Hospital
  • Principal Investigator: Lars Lundell, Professor, Karolinska University Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Lars Lundell, Professor, Karolinska University Hospital
ClinicalTrials.gov Identifier:
NCT02041065
Other Study ID Numbers:
  • 2011/2:4
  • 2011/2.4
First Posted:
Jan 20, 2014
Last Update Posted:
Sep 1, 2015
Last Verified:
Aug 1, 2015
Keywords provided by Lars Lundell, Professor, Karolinska University Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 1, 2015